Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castrate-sensitive Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07344779
What this trial is testing

Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer
Bayer 1,600
Not applicableStudy completedNCT07428642
What this trial is testing

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

Who this might be right for
Metastatic Hormone-Sensitive Prostate CancerProstate Cancer
First Affiliated Hospital of Wenzhou Medical University 168
Testing effectiveness (Phase 2)Study completedNCT04443062
What this trial is testing

Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Radboud University Medical Center 58
Early research (Phase 1)Looking for participantsNCT05818683
What this trial is testing

Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate NeoplasmsMetastatic Hormone-sensitive Prostate Cancer
Janssen Research & Development, LLC 300
Not applicableLooking for participantsNCT04983095
What this trial is testing

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticRadiation TherapyPositron-Emission Tomography
Karin Soderkvist 118
Large-scale testing (Phase 3)Looking for participantsNCT07723248
What this trial is testing

Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
ORIC Pharmaceuticals 600
Not applicableLooking for participantsNCT07290270
What this trial is testing

Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)

Who this might be right for
Metastatic Prostate Cancer
Novartis Pharmaceuticals 170
Early research (Phase 1)Study completedNCT05868057
What this trial is testing

A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets

Who this might be right for
Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproduction
Jiangsu HengRui Medicine Co., Ltd. 16
Not applicableLooking for participantsNCT07691697
What this trial is testing

PSMA PET-Staged Comprehensive Progression-Directed Radiotherapy for Limited Progression in Prostate Cancer

Who this might be right for
Oligoprogressive Prostate CancerMetastatic Prostate Cancer
Affidea Nu-med Center of Oncological DIagnostics and Therapy 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03246347
What this trial is testing

A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Wake Forest University Health Sciences 40
Testing effectiveness (Phase 2)Study completedNCT02649855
What this trial is testing

Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer

Who this might be right for
Prostate CancerProstate NeoplasmsNeoplasms, Prostatic
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)UnknownNCT04641078
What this trial is testing

Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic+2 more
University Hospital, Ghent 124
Large-scale testing (Phase 3)Study completedNCT04736199
What this trial is testing

Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Bayer 669
Large-scale testing (Phase 3)Active Not RecruitingNCT04497844
What this trial is testing

Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 696
Testing effectiveness (Phase 2)Study completedNCT03934840
What this trial is testing

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

Who this might be right for
Prostate Cancer
Masonic Cancer Center, University of Minnesota 61
Not applicableLooking for participantsNCT07172685
What this trial is testing

Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC

Who this might be right for
Prostate Cancer
Qilu Hospital of Shandong University 116
Testing effectiveness (Phase 2)Study completedNCT02278185
What this trial is testing

Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage III Prostate Cancer+1 more
University of Colorado, Denver 19
Not applicableLooking for participantsNCT06446401
What this trial is testing

The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Uppsala University 1,400
Very early researchNot Yet RecruitingNCT07674771
What this trial is testing

Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy Delivery

Who this might be right for
Prostate CancerCastration Sensitive Prostate CancerMetastatic Prostate Cancer+1 more
University of Texas Southwestern Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT05422911
What this trial is testing

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Who this might be right for
Metastatic CancerNeoplasm, ProstateCastrate-sensitive+1 more
Sun Pharmaceutical Industries Limited 192
Next Page